Breaking News Instant updates and real-time market news.

CZR

Caesars

$9.06

-0.055 (-0.60%)

, AVP

Avon Products

$3.61

-0.46 (-11.30%)

07:35
05/24/19
05/24
07:35
05/24/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Thursday in Caesars (CZR), Avon Products (AVP), Encana (ECA), Mosaic (MOS), Shutterfly (SFLY), PagSeguro Digital (PAGS), Kratos Defense (KTOS), Denbury Resources (DNR), Golar LNG (GLNG), and DXC Technology (DXC).

CZR

Caesars

$9.06

-0.055 (-0.60%)

AVP

Avon Products

$3.61

-0.46 (-11.30%)

ECA

Encana

$6.01

-0.48 (-7.40%)

MOS

Mosaic

$21.62

-0.72 (-3.22%)

SFLY

Shutterfly

$48.50

0.2 (0.41%)

PAGS

PagSeguro Digital

$31.37

0.12 (0.38%)

KTOS

Kratos Defense

$20.84

0.42 (2.06%)

DNR

Denbury Resources

$1.55

-0.17 (-9.88%)

GLNG

Golar LNG

$19.21

-0.78 (-3.90%)

DXC

DXC Technology

$52.00

-2.5 (-4.59%)

  • 29

    May

  • 24

    Jun

  • 07

    Aug

  • 13

    Nov

CZR Caesars
$9.06

-0.055 (-0.60%)

03/20/19
FBCO
03/20/19
INITIATION
Target $13
FBCO
Outperform
Caesars assumed with an Outperform at Credit Suisse
Credit Suisse analyst Ben Combes assumed coverage of Caesars with an Outperform rating and $13 price target.
01/18/19
MSCO
01/18/19
NO CHANGE
MSCO
Overweight
Morgan Stanley prefers Las Vegas to Macau in gaming entering 2019
Morgan Stanley analyst Thomas Allen said he is confident that the Las Vegas outlook is better than perceived after Q4 appears to have shown a meaningful rebound, noting also that his convention tracker supports strong 2019 demand growth and that flight capacity to the market is growing. Meanwhile, as a firm, Morgan Stanley has cut its Macau market gaming revenue outlook and industry view, Allen noted. Combining his Las Vegas outlook and bullish stance on regional U.S. gaming, Allen called MGM Resorts (MGM) and Caesars (CZR) his preferred large cap gaming stocks entering 2019, stating that he believes expectations for both are beatable. He reiterates Overweight ratings on both, as well as on Las Vegas Sands (LVS), and keeps an Equal Weight rating on Wynn Resorts (WYNN).
01/16/19
BOFA
01/16/19
DOWNGRADE
Target $9
BOFA
Neutral
Caesars downgraded to Neutral following rally at BofA/Merrill
BofA/Merrill analyst Shaun Kelley downgraded Caesars to Neutral from Buy and lowered its price target to $9. Kelley is using the rally year-to-date in shares to downgrade saying he is more cautious longer-term towards Las Vegas pricing power and growth.
03/20/19
JPMS
03/20/19
NO CHANGE
Target $60
JPMS
Overweight
Eldorado shares could be worth $72-$80 with Caesars deal, says JPMorgan
JPMorgan analyst Daniel Politzer estimates that an Eldorado Resorts (ERI) acquisition of Caesars Entertainment (CZR) could generate $300M in synergies, imply a valuation of $72-$80 per share, and be ~50% accretive on a free cash flow per share basis. Reuters reported over the weekend that the two companies are in merger talks. The analyst's scenario contemplates Eldorado acquiring Caesars for $10.50 per share, or a 23% premium to last night's close, with the offer consisting of $6.25 in cash and $4.25 worth of stock. Politzer keeps an Overweight rating on Eldorado Resorts with a $60 price target.
AVP Avon Products
$3.61

-0.46 (-11.30%)

05/23/19
DADA
05/23/19
DOWNGRADE
Target $3.6
DADA
Neutral
Avon Products downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser downgraded Avon Products to Neutral and lowered her price target to $3.60 from $4.75 after the confirmation by Natura that it is acquiring the company.
05/10/19
SBSH
05/10/19
NO CHANGE
SBSH
Natura paying 50% premium for Avon 'not the base case,' says Citi
Citi analyst Tobias Stingelin noted that Spanish website Intereconomia.com reported, citing a source, that Santander's board has approved a loan of up to $2.1B for Natura, which he notes has already publicly announced that it is engaged in talks to buy Avon. An all cash transaction of $2.1B, or a 50% premium, is unlikely in his view and he does not believe that this is the base case, Stingelin tells investors. He believes that if a transaction were to take place for Avon it would be at a lower premium and noted that Intereconomia's source said a deal could still be for a combination of cash and stock. Stingelin has a Neutral rating on Natura shares. In afternoon trading, Avon shares are up nearly 10% to $3.18.
09/24/18
09/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Plains All American (PAA) and Plains GP Holdings (PAGP) were upgraded to Buy from Hold at Stifel. 2. Avon Products (AVP) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the increased "sense of urgency" under the new CEO Jan Zijderveld displayed in his first analyst meeting, demonstrating his greater engagement in the company's operations, hiring of executives with sales experience, and "establishing a culture of accountability." 3. United Natural Foods (UNFI) upgraded to Sector Perform at RBC Capital with analyst William Kirk saying while core business challenges for the company remain and the risk of the Supervalu acquisition integration continues, its 6.4-times earnings valuation likely accounts for these issues. 4. KVH Industries (KVHI) upgraded to Buy from Neutral at Chardan with analyst James McIlree saying he expects "continued strong growth" from its Agile Plans that should result in improved margins and increased financial predictability. 5. RELX (RELX) upgraded to Overweight from Equal Weight at Barclays with analyst Nick Dempsey saying he views the current valuation as attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/25/19
DADA
03/25/19
NO CHANGE
Target $3.5
DADA
Buy
Avon Products buyout could be valued as high as $4.50/shr, says DA Davidson
DA Davidson analyst Linda Bolton Weiser kept her Buy rating and $3.50 price target on Avon Products after the latest speculation about its potential acquisition by Natura. The analyst believes that the takeout valuation could come at $3.80-$4.50 per share, but intends to assess the Brazil anti-trust rules while also noting Natura's already "leveraged balance sheet, with over $2B of debt and debt-to-EBITDA of 4.3-times".
ECA Encana
$6.01

-0.48 (-7.40%)

05/01/19
05/01/19
DOWNGRADE

Market Perform
Encana downgraded to Market Perform at Bernstein
As previously reported, Bernstein analyst Bob Brackett downgraded Encana to Market Perform from Outperform after the company reported quarterly results, and as he sees relatively fewer catalysts for remainder of 2019. Further, in terms of share buybacks, the analyst notes that at 60% complete have failed to re-rate the stock.
04/30/19
BERN
04/30/19
DOWNGRADE
BERN
Market Perform
Encana downgraded to Market Perform from Outperform at Bernstein
04/29/19
JPMS
04/29/19
DOWNGRADE
Target $12
JPMS
Neutral
Encana resumed with a Neutral from Overweight at JPMorgan
JPMorgan analyst Arun Jayaram resumed coverage of Encana and downgraded the shares to Neutral from Overweight with a $12 price target. The analyst has a "positive" bias on the shares, but he wants to wait for additional drilling results from the company's acquired NFX STACK acreage before revisiting his Neutral thesis.
04/12/19
GSCO
04/12/19
NO CHANGE
GSCO
Goldman downgrades California Resources, Chesapeake to Sell, upgrades Murphy
Within the Exploration and Production space, Goldman Sachs analyst Brian Singer recommends selling stocks where the valuation post recent rallies "appears at odds" with the company's competitive positioning. With that in mind, Singer downgraded both California Resources (CRC) and Chesapeake Energy (CHK) to Sell from Neutral. California Resources has a low decline rate and competitive supply cost but unfavorable debt cost that does not warrant the extent of its current valuation premium, says the analyst. For Chesapeake, Singer sees less favorable supply cost and corporate returns. The analyst also upgraded Murphy Oil (MUR) to Neutral from Sell. He believes the stock's current valuation appears more in line with its competitive positioning. Singer recommends buying "low cost oil suppliers" Encana (ECA), Parsley Energy (PE), Pioneer Natural (PXD) and EOG Resources (EOG) and Chevron (CVX).
MOS Mosaic
$21.62

-0.72 (-3.22%)

05/08/19
JPMS
05/08/19
UPGRADE
Target $27
JPMS
Overweight
Mosaic upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas upgraded Mosaic to Overweight from Neutral while lowering his price target for the shares to $27 from $33.
05/08/19
JPMS
05/08/19
UPGRADE
Target $27
JPMS
Overweight
JPMorgan upgrades Mosaic to Overweight on favorable risk/reward
JPMorgan analyst Jeffrey Zekauskas upgraded Mosaic to Overweight from Neutral while lowering his price target for the shares to $27 from $33. Following the stock's underperformance on a one, three, five, and ten year period, Mosaic shares now offer a favorable risk/reward balance, Zekauskas tells investors in a research note. Mosaic's approach to value creation is now simpler, and its 2019 performance is "probably anomalously low, which we think creates a positive trading opportunity," says the analyst. He expects Mosaic's free cash flow yield to approach 12% in 2020. At current trading levels, Mosaic is the most inexpensive of the fertilizer companies by a "wide margin," according to Zekauskas.
05/08/19
05/08/19
UPGRADE
Target $28

Outperform
Mosaic upgraded to Outperform on 'apparent' value at Credit Suisse
As previously reported, Credit Suisse analyst Christopher Parkinson upgraded Mosaic to Outperform from Neutral as he believes global phosphate prices have limited downside risk to Chinese marginal costs, lower ammonia/sulfur prices will offset recent regional price degradation, potash prices will remain at current levels for the time being, issues in Brazil are transitory, and the situation in the U.S. is likely to normalize by fall. The analyst also lowered his price target on the shares to $28 from $30.
05/08/19
05/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mosaic (MOS) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas stating that following the stock's underperformance on a one, three, five, and ten year period, Mosaic shares now offer a favorable risk/reward balance. 2. Qorvo (QRVO) upgraded to Buy from hold at Canaccord with analyst T. Michael Walkley saying he expects Qorvo to remain focused on developing integrated solutions to drive dollar content growth to grow faster than the slow growing smartphone market and anticipates improving growth trends as 5G ramps in F2021. 3. LendingClub (LC) upgraded to Outperform from Neutral at Wedbush with analyst Henry Coffey sayinh the company now operates with a more complex, more diversified source of loan buying/funding, a tighter focus around its primary credit niche, and a focus on operating efficiency that has it within eyesight of generating an adjusted EBITDA margin of 20% by the end of 2019. 4. US Foods (USFD) upgraded to Buy from Neutral at Buckingham with analyst Bob Summers continuing to have a "very favorable" sector view as he believes that food away from home trends will continue and the industry fragmentation favors large, well-capitalized operators. 5. Office Properties (OPI) upgraded to Hold from Underperform at Jefferies with analyst Jonathan Petersen noting the market now well understands the earnings dilution from the FPO acquisition. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SFLY Shutterfly
$48.50

0.2 (0.41%)

04/26/19
RAJA
04/26/19
UPGRADE
Target $56
RAJA
Outperform
Shutterfly upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Aaron Kessler upgraded Shutterfly to Outperform from Market Perform with a $56 price target, citing stable Consumer segment growth trends and his expectation for improved consumer growth throughout 2019, as well as "very achievable" 2021 EBITDA guidance of $400M-$450M with modest organic growth assumptions and modest Lifetouch synergies baked in. Additionally, Kessler says he believes valuation is attractive and that the company's ongoing strategic review could serve as a catalyst, with Bloomberg recently reporting interest from private equity firms.
04/26/19
04/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cleveland-Cliffs (CLF) upgraded to Outperform from Neutral at Credit Suisse with analyst Curt Woodworth saying he sees potential value near $16-$18 once the HBI plant is fully ramped, even with low hot-rolled coil prices at that point in time. 2. Argo Group (ARGO) upgraded to Outperform from Market Perform at William Blair with analyst Adam Klauber saying Argo is beginning to emerge as a long-term midcap growth insurer, Klauber tells investors in a research note. 3. Illinois Tool Works (ITW) upgraded to Neutral from Underweight at JPMorgan with analyst Ann Duignan saying following the company's "solid" Q1 results, downside risk to 2019 earnings estimates "appears limited," with the worst of auto builds and European weakness "likely behind us." 4. The Medicines Co. (MDCO) upgraded to Buy from Neutral at Goldman Sachs while Esperion (ESPR) upgraded to Neutral from Sell. 5. Shutterfly (SFLY) upgraded to Outperform from Market Perform at Raymond James with analyst Aaron Kessler citing stable Consumer segment growth trends and his expectation for improved consumer growth throughout 2019, as well as "very achievable" 2021 EBITDA guidance of $400M-$450M with modest organic growth assumptions and modest Lifetouch synergies baked in. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/26/19
RAJA
04/26/19
UPGRADE
RAJA
Outperform
Shutterfly upgraded to Outperform from Market Perform at Raymond James
02/06/19
AGIS
02/06/19
NO CHANGE
Target $55
AGIS
Buy
Shutterfly investors' 'best bet' is to hang on in hopes for deal, says Aegis
Aegis analyst Victor Anthony said Shutterfly had an "eventful" evening yesterday, as the company reported revenue and adjusted EBITDA that missed his estimates, gave guidance that also missed his and consensus estimates, pushed out its synergy targets, announced the departure of its CEO and announced it had been approached about a potential acquisition and is exploring alternatives. Anthony, who notes that he previously highlighted Shutterfly as a potential acquisition target or the target of activist investors, believes that "the best bet for investors is to hang onto the shares in anticipation of an acquirer stepping in." A financial buyer could pay $60 per share, while a strategic acquirer could pay $70 per share, believes Anthony, who has a Buy rating and $55 price target on Shutterfly shares.
PAGS PagSeguro Digital
$31.37

0.12 (0.38%)

05/16/19
GUGG
05/16/19
UPGRADE
Target $33
GUGG
Buy
PagSeguro Digital upgraded to Buy on financial services expansion at Guggenheim
As previously reported, Guggenheim analyst Jeff Cantwell upgraded PagSeguro Digital to Buy from Neutral after the company announced a product expansion in financial services, which he sees significantly improving its long-term revenue and earnings outlook. He believes its new financial services, such as PagBank, are highly complementary with PagSeguro's existing platform and that the move increases the company's total addressable market significantly, Cantwell tells investors. He set a $33 price target on PagSeguro shares.
05/16/19
GUGG
05/16/19
UPGRADE
GUGG
Buy
PagSeguro Digital upgraded to Buy from Neutral at Guggenheim
05/08/19
05/08/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. PagSeguro Digital (PAGS) initiated with a Reduce at HSBC. 2. StoneCo (STNE) initiated with a Reduce at HSBC. 3. Tecnoglass (TGLS) initiated with an Outperform at Raymond James. 4. Pinterest (PINS) initiated with a Neutral at Rosenblatt. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/07/19
HSBC
05/07/19
INITIATION
Target $24
HSBC
Reduce
PagSeguro Digital initiated with a Reduce at HSBC
HSBC started PagSeguro Digital with a Reduce rating and $24 price target.
KTOS Kratos Defense
$20.84

0.42 (2.06%)

03/07/19
ADAM
03/07/19
NO CHANGE
Target $20
ADAM
Buy
Kratos Defense's Valkyrie test success a very positive catalyst, says Canaccord
Canaccord analyst Ken Herbert said the Kratos Defense test flight of Valkyrie was a success, which he believes should be a very positive catalyst and should contribute to investor confidence in the company's ability to successfully execute on its development opportunities. Herbert reiterated his Buy rating and $20 price target on Kratos Defense shares.
05/24/19
JPMS
05/24/19
UPGRADE
Target $24
JPMS
Overweight
Kratos Defense upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Seth Seifman upgraded Kratos Defense & Securities Solutions to Overweight from Neutral and raised his price target for the shares to $24 from $18.
05/24/19
JPMS
05/24/19
UPGRADE
Target $24
JPMS
Overweight
JPMorgan upgrades Kratos to Overweight on Valkyrie drone progress
JPMorgan analyst Seth Seifman upgraded Kratos Defense & Securities Solutions to Overweight from Neutral and raised his price target for the shares to $24 from $18. Kratos has made good progress on "several fronts," the most important being its Valkyrie tactical drone, which has gained the attention of Air Force, Seifman tells investors in a research note. While the Valkyrie will not bring an "earnings windfall near term," milestones on it and other programs should help Kratos shares "for the time being," says the analyst. Further, he believes the company's base business is performing well.
03/01/19
BARD
03/01/19
NO CHANGE
Target $19
BARD
Outperform
Kratos Defense should be bought aggressively on pullbacks, says Baird
Baird analyst Peter Arment said he would be an aggressive buyer of Kratos Defense on pullbacks. The analyst sees potential weakness from the mixed Q4 results as the Valkyrie tactical drone is soon slated for its first flight. Arment reiterated his Outperform rating and $19 price target on Kratos Defense shares.
DNR Denbury Resources
$1.55

-0.17 (-9.88%)

03/22/19
NORL
03/22/19
UPGRADE
NORL
Outperform
Penn Virginia upgraded to Outperform on valuation at Northland
Northland analyst Jeff Grampp upgraded Penn Virginia to Outperform from Neutral with an $82 price target following the termination of the Denbury Resources (DNR) merger. Grampp views Penn shares as attractively valued and said the company is well positioned financially.
01/08/19
JRCO
01/08/19
DOWNGRADE
JRCO
Hold
Denbury Resources downgraded to Hold from Accumulate at Johnson Rice
12/20/18
SOCO
12/20/18
DOWNGRADE
SOCO
Underweight
Denbury Resources downgraded to Underweight from Overweight at Capital One
12/06/18
SPHN
12/06/18
INITIATION
Target $4
SPHN
Equal Weight
Denbury Resources initiated with an Equal Weight at Stephens
Stephens analysts Gail Nicholson and Drew Lipke began coverage of the E&P sector with a positive outlook, starting Denbury Resources with an Equal Weight rating and $4 price target.
GLNG Golar LNG
$19.21

-0.78 (-3.90%)

12/21/18
EVER
12/21/18
NO CHANGE
Target $42
EVER
Outperform
Golar LNG Tortue project worth $10 per share to equity, says Evercore ISI
After Kosmos Energy (KOS) and BP (BP), the equity owners in the Greater Tortue Ahmeyim project offshore Senegal and Mauritania, announced Final Investment Decision on Phase 1, which will utilize one of Golar LNG's (GLNG) FLNG vessels, Evercore ISI analyst Jonathan Chappell said he continues to estimate a nearly $10/share value to Golar LNG equity based on the expected output, start-up time, and financing. Stating that Tortue means "an awful lot" for Golar LNG, he reiterated his Outperform rating on the stock and trimmed his target to $42 from $43.
02/08/19
SCOT
02/08/19
INITIATION
Target $34
SCOT
Outperform
Golar LNG initiated with an Outperform at Scotiabank
Scotiabank analyst Alonso Guerra-Garcia initiated Golar LNG with an Outperform and $34 price target.
02/26/19
JEFF
02/26/19
NO CHANGE
Target $40
JEFF
Buy
Golar LNG expected to report Q4 EBITDA well above Street at Jefferies
Jefferies analyst Randy Giveans expects Golar LNG to report Q4 EBITDA of $130M, well ahead of Street consensus of $95M, due to the company's vessels in the Cool Pool achieving TCE rates of ~$100,000 per day. The analyst also expects Golar to provide updates on its FLNG and Golar Power projects. He keeps a Buy rating on the shares with a $40 price target.
05/13/19
JEFF
05/13/19
NO CHANGE
Target $35
JEFF
Buy
Jefferies says go long Golar LNG with stock at three-year low
Jefferies analyst Randy Giveans tells investors to go long shares of Golar LNG following the stock's recent underperformance. Golar LNG is trading at a three-year low despite positive news, an attractive industry outlook, and affirmative management guidance regarding new projects, Giveans tells investors in a research note. He believes the shares are trading at a price that does not reflect the true value of Golar LNG based on his sum-of-the-parts valuation. The analyst keeps a Buy rating on the shares with a $35 price target.
DXC DXC Technology
$52.00

-2.5 (-4.59%)

05/24/19
WELS
05/24/19
NO CHANGE
Target $55
WELS
Market Perform
DXC Technology price target lowered to $55 from $72 at Wells Fargo
Wells Fargo analyst Edward Caso lowered his price target for DXC Technology to $55 from $72 citing the company's Q4 revenue miss and "weak" fiscal 2020 guidance. DXC talking about current contract give ups in exchange for future digital work suggests ongoing margin pressure, Caso tells investors in a post-earnings research note. He keeps a Market Perform rating on the shares.
05/21/19
BMOC
05/21/19
NO CHANGE
Target $70
BMOC
Outperform
DXC Technology price target lowered to $70 from $82 at BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on DXC Technology to $70, adjusting his model to reflect his rolled out 6-times enterprise value to expected FY21 EBITDA multiple. The analyst also keeps his Outperform rating on the stock, saying its future value will be sustained by the company's growing revenues and realized cost savings. Bachman adds that he expects DXC Technology to grow its revenue by up to 1% in the second half of FY20 and in FY21, with even "modest" organic growth being well received by investors.
05/20/19
KEYB
05/20/19
NO CHANGE
Target $88
KEYB
Overweight
DXC Technology price target lowered to $88 from $97 at KeyBanc
KeyBanc analyst Arvind Ramnani lowered his price target for DXC Technology to $88 from $97, while reiterating an Overweight rating on the shares. The analyst notes that DXC has largely underperformed the S&P 500 year to date as investors are skeptical about its transition to a revenue growth story and Street expectations have been mismanaged. Despite negative investor sentiment, Ramnani finds risk/reward to be attractive at these levels, with DXC having one of the lowest valuations in tech.
04/22/19
GSCO
04/22/19
DOWNGRADE
GSCO
Buy
DXC Technology downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst James Schneider removed DXC Technology from the Conviction Buy List and maintained a Buy rating saying shares could remain range bound near-term given revenue declines over the next two quarters given the pending acquisition of Luxoft. The analyst continues to see compelling value in shares and believes the Street's earnings estimates are too low.

TODAY'S FREE FLY STORIES

PYPL

PayPal

$118.65

-1.22 (-1.02%)

, V

Visa

$179.18

-1.34 (-0.74%)

08:31
07/20/19
07/20
08:31
07/20/19
08:31
Periodicals
MasterCard, Visa among best stocks to play fintech boom, Barron's says »

The fintech units within…

PYPL

PayPal

$118.65

-1.22 (-1.02%)

V

Visa

$179.18

-1.34 (-0.74%)

MA

MasterCard

$275.51

-1.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 30

    Jul

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

, SBNY

Signature Bank

$123.87

1.07 (0.87%)

08:28
07/20/19
07/20
08:28
07/20/19
08:28
Periodicals
KeyCorp, U.S. Bancorp better positioned for Fed rate cut, Barron's says »

KeyCorp (KEY), Signature…

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

SBNY

Signature Bank

$123.87

1.07 (0.87%)

KEY

KeyCorp

$17.45

0.15 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

  • 16

    Oct

CMG

Chipotle

$746.80

-17.43 (-2.28%)

08:24
07/20/19
07/20
08:24
07/20/19
08:24
Periodicals
Chipotle stock made 'stunning' comeback, Barron's says »

Chipotle's stock is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Sep

BYND

Beyond Meat

$176.65

6.28 (3.69%)

07:40
07/20/19
07/20
07:40
07/20/19
07:40
Periodicals
Beyond Meat could spike after earnings, Barron's says »

After rising so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

NFLX

Netflix

$315.10

-10.04 (-3.09%)

07:37
07/20/19
07/20
07:37
07/20/19
07:37
Periodicals
Netflix's problems have only just begun, Barron's says »

Netflix has a problem and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, TGT

Target

$88.02

-0.48 (-0.54%)

07:34
07/20/19
07/20
07:34
07/20/19
07:34
Periodicals
Time to aim higher on Target's stock, Barron's says »

As retailers have…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

TGT

Target

$88.02

-0.48 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 21

    Aug

  • 19

    Sep

  • 25

    Sep

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, FDX

FedEx

$167.08

1.69 (1.02%)

07:31
07/20/19
07/20
07:31
07/20/19
07:31
Periodicals
FedEx ups game amid e-commerce growth, Barron's says »

It is time to embrace…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

FDX

FedEx

$167.08

1.69 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

07:27
07/20/19
07/20
07:27
07/20/19
07:27
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

ORCL

Oracle

$57.55

-0.58 (-1.00%)

AZN

AstraZeneca

$40.11

-0.61 (-1.50%)

BMY

Bristol-Myers

$43.32

-0.72 (-1.63%)

LLY

Eli Lilly

$106.75

-1.57 (-1.45%)

GSK

GlaxoSmithKline

$40.97

-0.44 (-1.06%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

MRK

Merck

$81.39

-1.28 (-1.55%)

NVS

Novartis

$93.58

-0.715 (-0.76%)

PFE

Pfizer

$42.78

-0.28 (-0.65%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$41.94

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 30

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 27

    Aug

  • 28

    Aug

  • 02

    Sep

  • 09

    Sep

  • 16

    Sep

  • 16

    Sep

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 02

    Oct

  • 15

    Oct

  • 04

    Nov

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

18:12
07/19/19
07/19
18:12
07/19/19
18:12
Hot Stocks
Biohaven receives CRL from FDA for application seeking NURTEC approval »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

CE

Celanese

$107.01

0.9 (0.85%)

18:01
07/19/19
07/19
18:01
07/19/19
18:01
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

F

Ford

$10.20

-0.06 (-0.58%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Periodicals
Ford plans to lay off 185 employees at Ontario plant, Reuters reports »

A union local said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 23

    Oct

RTN

Raytheon

$178.55

2.45 (1.39%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Hot Stocks
Raytheon awarded $191.01M Air Force contract modification »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UTX

United Technologies

$132.37

1.08 (0.82%)

17:44
07/19/19
07/19
17:44
07/19/19
17:44
Hot Stocks
United Technologies awarded $253.71M Air Force contract »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LMT

Lockheed Martin

$356.90

0.675 (0.19%)

17:40
07/19/19
07/19
17:40
07/19/19
17:40
Hot Stocks
Lockheed Martin awarded $1.47B Missile Defense Agency contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ARES

Ares Management

$28.13

-0.305 (-1.07%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Syndicate
Breaking Syndicate news story on Ares Management »

Ares Management files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

HAFC

Hanmi Financial

$21.68

-0.105 (-0.48%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Hot Stocks
Hanmi Financial to delay release of Q2 results »

Hanmi Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PAYS

Paysign

$17.49

-0.48 (-2.67%)

17:32
07/19/19
07/19
17:32
07/19/19
17:32
Syndicate
Breaking Syndicate news story on Paysign »

Paysign files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$43.19

0.83 (1.96%)

17:28
07/19/19
07/19
17:28
07/19/19
17:28
Hot Stocks
Methanex reaches final investment decision on methanol plant in Geismar, LA »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

17:17
07/19/19
07/19
17:17
07/19/19
17:17
Conference/Events
Credit Suisse biotech analysts to hold an analyst/industry conference call »

Biotech Analysts provide…

17:14
07/19/19
07/19
17:14
07/19/19
17:14
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

SHIP

Seanergy Marine

$0.64

-0.0425 (-6.25%)

17:05
07/19/19
07/19
17:05
07/19/19
17:05
Hot Stocks
Seanergy Maritime receives noncompliance notice from Nasdaq »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONM

Sonim

$13.42

0.24 (1.82%)

16:41
07/19/19
07/19
16:41
07/19/19
16:41
Conference/Events
Sonim management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

KINS

Kingstone Companies

$8.81

0.09 (1.03%)

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Hot Stocks
Kingstone names Barry Goldstein CEO »

Kingstone Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Options
Preliminary option volume of 22.6M today »

Preliminary option volume…

BA

Boeing

$377.34

16.17 (4.48%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

16:24
07/19/19
07/19
16:24
07/19/19
16:24
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks were tentatively…

BA

Boeing

$377.34

16.17 (4.48%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

AAPL

Apple

$202.62

-3.02 (-1.47%)

WMT

Walmart

$113.91

-0.77 (-0.67%)

DIS

Disney

$139.86

-1.76 (-1.24%)

GCI

Gannett

$9.43

1.53 (19.37%)

CRWD

Crowdstrike

$83.50

10.75 (14.78%)

SKX

Skechers

$39.00

4.25 (12.23%)

PACB

Pacific Biosciences

$5.34

-0.53 (-9.03%)

ILMN

Illumina

$293.10

-5.44 (-1.82%)

CHWY

Chewy

$30.70

-2.09 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 15

    Aug

  • 03

    Sep

  • 25

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.